Digital Look

Welcome to Digital Look++,
you are not logged in

Animalcare Group (ANCR)

Pharma and Biotech

230.00p

	£ (Millions)	£ (Millions)
Cash Flow Statement	30-Jun-09	30-Jun-08

Net Cash Flow From Operating Activities	2.43	1.46
ROI, Servicing of Finance
Assocs/JV Dividends Received	_bn/a	_bn/a
Interests & Other Dividends Received	n/a	n/a
Interest Paid	_bn/a	_bn/a
Minorities & Non-Equity Divs Paid	_bn/a	_bn/a
	n/a	n/a

Taxation Paid	_bn/a	_bn/a

Gross Cash Flow	_bn/a	_bn/a

Capital Expd & Financial Inv
Interests & Other Dividends Received	n/a	n/a
Disposal of Property, Plant & Equipment	0.02	0.02
Disposal of Investments	n/a	n/a
Purchase of Property, Plant & Equipment	(0.34)	(0.19)
Purchase of Investments	n/a	(14.40)
Net Purchase of Intangible Assets	(0.31)	(0.22)
Other Investing Cash Flow	n/a	(0.05)
	(0.63)	(14.83)
Financing Activities
Dividends Paid	n/a	n/a
Repayments of Borrowings	(1.23)	(0.22)
Borrowings	n/a	6.90
Other Financing Cash Flow	n/a	7.70
	(1.23)	14.38
Net Increase/Decrease In Cash	0.15	0.88

Key Financials	30-Jun-09	30-Jun-08

Shares in Issue - Year End	19.76	19.76

Financial Data
Cash Incr/Decr per Share	0.75p	7.59p
Operating Cash Flow per Share	12.31p	12.55p
Gross Cash Flow per Share	_bn/a	_bn/a

Market Data
Price/Operating Cash Flow	8.1	4.6

* GAAP

a. Operating activities before tax

b. Not disclosed under IFRS

c. Not previously included in financing activities

d. Based on operating cash flow before tax

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.